Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something? - Takeaways - MDSpire

Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something?

  • By

  • Riccardo Gili

  • Luigi Lorini

  • Davide Smussi

  • Armando Di Bello

  • Paolo Bossi

  • Carlo Resteghini

  • July 1, 2026

Share

  • 1

    Tobacco exposure significantly influences risk and outcomes in head and neck squamous cell carcinoma (HNSCC).

  • 2

    Smoking duration is a stronger predictor of HNSCC risk and survival than cumulative pack-years, especially in long-term smokers.

  • 3

    Alternative metrics like log cigarette-years provide better prognostic accuracy compared to traditional pack-years.

  • 4

    Smoking cessation and the use of alternative tobacco products independently affect HNSCC risk and treatment outcomes.

  • 5

    Current models for smoking exposure in HNSCC should integrate duration and alternative tobacco use for improved risk stratification.

Original Source(s)

Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something?

  • by Riccardo Gili, Luigi Lorini, Davide Smussi, Armando Di Bello, Paolo Bossi, Carlo Resteghini

  • July 1, 2026

Related Content

Financial distress among women with advanced or metastatic breast cancer in Germany: secondary analysis of prospective ePROCOM data of a two-center cohort

Distribution and function of human long-lasting T cells in aging and non-small cell lung cancer

Ferroptosis contributes to quercetin-induced anti-cancer activity through blockade of LGR4/NF-κB/GPX4 axis in oral squamous cell carcinoma